Zobrazeno 1 - 10
of 159
pro vyhledávání: '"Theresa A, Shapiro"'
Autor:
Victoria A. Balta, Deborah Stiffler, Abeer Sayeed, Abhai K. Tripathi, Rubayet Elahi, Godfree Mlambo, Rahul P. Bakshi, Amanda G. Dziedzic, Anne E. Jedlicka, Elizabeth Nenortas, Keyla Romero-Rodriguez, Matthew A. Canonizado, Alexis Mann, Andrew Owen, David J. Sullivan, Sean T. Prigge, Photini Sinnis, Theresa A. Shapiro
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-9 (2023)
Abstract Long-acting injectable medications, such as atovaquone, offer the prospect of a “chemical vaccine” for malaria, combining drug efficacy with vaccine durability. However, selection and transmission of drug-resistant parasites is of concer
Externí odkaz:
https://doaj.org/article/4b2f7c80b9964c198820bdffbbda7944
Autor:
David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Debora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Malcolm DeCamp, Thomas J. Dilling, Jonathan Dowell, Gregory A. Durm, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aparna Hegde, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Sandip P. Patel, Tejas Patil, Patricio M. Polanco, Gregory J. Riely, Jonathan Riess, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, Miranda Hughes
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:340-350
The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) provide recommendations for management of disease in patients with NSCLC. These NCCN Guidelines Insights focus on neoadjuvant and adjuvant (also known as perioperative) systemic therapy opt
Autor:
Rahul P. Bakshi, Lee M. Tatham, Alison C. Savage, Abhai K. Tripathi, Godfree Mlambo, Matthew M. Ippolito, Elizabeth Nenortas, Steve P. Rannard, Andrew Owen, Theresa A. Shapiro
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-8 (2018)
Long-acting antimalarials could provide improved prophylaxis and treatment options in the field. Here, Bakshi et al. develop a long-acting injectable atovaquone nanomedicine that prevents malaria infection prophylactically for up to 4 weeks in mice w
Externí odkaz:
https://doaj.org/article/e2bbca833b9043c393d3ffbbdc23b805
Autor:
Victoria A. Balta, Deborah Stiffler, Abeer Sayeed, Abhai K. Tripathi, Rubayet Elahi, Godfree Mlambo, Rahul P. Bakshi, Amanda G. Dziedzic, Anne E. Jedlicka, Elizabeth Nenortas, Keyla Romero-Rodriguez, Matthew A. Canonizado, Alexis Mann, Andrew Owen, David J. Sullivan, Sean T. Prigge, Photini Sinnis, Theresa A. Shapiro
Publikováno v:
bioRxiv
Rising numbers of malaria cases and deaths underscore the need for new interventions. Long-acting injectable medications, such as those now in use for HIV prophylaxis, offer the prospect of a malaria “chemical vaccine”, combining the efficacy of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8adb17cfb4ac3652a40f6dd9c6651947
https://doi.org/10.1101/2023.02.07.527535
https://doi.org/10.1101/2023.02.07.527535
Autor:
Jessica Bauman, Alda Tam, Christine M. Lovly, Scott N. Gettinger, Daniel Morgensztern, Aditi P. Singh, Steven E. Schild, Miranda Hughes, Lucian R. Chirieac, Debora S. Bruno, Erminia Massarelli, Aparna Hegde, Renato Martins, Jane Yanagawa, Thomas Ng, Ankit Bharat, Billy W. Loo, Douglas E. Wood, Matthew A. Gubens, Theresa A. Shapiro, Mark Hennon, Gregory J. Riely, Gregory A. Otterson, James P. Stevenson, Rudy P. Lackner, Kristina M. Gregory, Joe Y. Chang, Dara L. Aisner, Jules Lin, Jonathan E. Dowell, Sandip P. Patel, Stephen C. Yang, Thomas A. D'Amico, Wallace Akerley, Thomas J. Dilling, David S. Ettinger, Michael Lanuti, Ticiana A. Leal
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:254-266
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines regarding targeted
Autor:
David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Debora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Malcolm DeCamp, Thomas J. Dilling, Jonathan Dowell, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aparna Hegde, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Jose M. Pacheco, Sandip P. Patel, Gregory J. Riely, Jonathan Riess, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina Gregory, Miranda Hughes
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 20(5)
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell Lung Cancer (NSCLC) provide recommended management for patients with NSCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent treatmen
Autor:
Julia C. Pringle, Mwiche Siame, Jonathan J. Juliano, William J. Moss, Steven R. Meshnick, Liusheng Huang, Peter O Oluoch, Matthew M. Ippolito, Philip E. Thuma, Jeffrey A. Bailey, Ozkan Aydemir, Francesca T. Aweeka, Theresa A. Shapiro, Ben Katowa
Publikováno v:
The American journal of tropical medicine and hygiene, vol 103, iss 6
Am J Trop Med Hyg
Am J Trop Med Hyg
Artemether–lumefantrine (AL) is a first-line agent for uncomplicated malaria caused by Plasmodium falciparum. The WHO recommends periodic therapeutic efficacy studies of antimalarial drugs for the detection of malaria parasite drug resistance and t
Autor:
Theresa A. Shapiro, Gary H. Posner, Nirbhay Kumar, Bryan T. Mott, Vandana Singhal, Lauren E. Woodard
Publikováno v:
Pharmaceuticals, Vol 2, Iss 3, Pp 228-235 (2009)
Three thermally and hydrolytically stable silylamide trioxanes have been prepared from the natural trioxane artemisinin in only five simple chemical steps and in at least 56% overall yield. Two of these new chemical entities completely cured malariai
Externí odkaz:
https://doaj.org/article/73d88e2847ad49beab26f7b93ff74b1b
Autor:
Matthew M, Ippolito, Jean-Bertin B, Kabuya, Manuela, Hauser, Luc K, Kamavu, Proscovia Miiye, Banda, Lisa R, Yanek, Rubab, Malik, Modest, Mulenga, Jeffrey A, Bailey, Gershom, Chongwe, Thomas A, Louis, Theresa A, Shapiro, William J, Moss
Publikováno v:
Clin Infect Dis
BACKGROUND: Severe malaria resulting from Plasmodium falciparum infection is the leading parasitic cause of death in children worldwide, and severe malarial anemia (SMA) is the most common clinical presentation. The evidence in support of current blo